The aminobisphosphonate zoledronic acid(ZOL) has elicited significant attention due to its remarkable anti-tumoral activity,though its detailed mechanism of action remains unclear. Here,we demonstrate the existence of a nuclear GSK3-NFATc2 stabilization pathway that promotes cancer growth in vitro and in vivo and serves as a bonafide target of ZOL. Specifically, the serine/threonine kinase GSK3 stabilizes nuclear NFATc2 through phosphorylation of the serine-rich SP2 domain, thus protecting the transcription ...
The aminobisphosphonate zoledronic acid(ZOL) has elicited significant attention due to its remarkable anti-tumoral activity,though its detailed mechanism of action remains unclear. Here,we demonstrate the existence of a nuclear GSK3-NFATc2 stabilization pathway that promotes cancer growth in vitro and in vivo and serves as a bonafide target of ZOL. Specifically, the serine/threonine kinase GSK3 stabilizes nuclear NFATc2 through phosphorylation of the serine-rich SP2 domain, thus protecting the transcription factor from E3-ubiquitin ligase HDM2 mediated proteolysis. ZOL disrupts this NFATc2 stabilization pathway through two mechanisms, namely GSK3 inhibition and induction of HDM2 activity. Upon nuclear accumulation,HDM2 targets unphosphorylated NFATc2 for ubiquitination at acceptor lysine residues K-684/K-897 and hence labels the factor for subsequent proteasomal degradation. Conversely, mutagenesis induced constitutive serine phosphorylation of the SP2 domain prevents NFATc2 from HDM2 mediated ubiquitination and degradation by ZOL. In conclusion, this report demonstrates a critical role of the GSK3-HDM2 signaling loop in the regulation of NFATc2 protein stability.
Product dimensions: 0.28 (w) x 6.00 (h) x 9.00 (d)
Customer Reviews
Be the first to write a review
( 0 )
Rating Distribution
5 Star
(0)
4 Star
(0)
3 Star
(0)
2 Star
(0)
1 Star
(0)
Barnes & Noble.com Review Rules
Our reader reviews allow you to share your comments on titles you liked,
or didn't, with others. By submitting an online review, you are representing to
Barnes & Noble.com that all information contained in your review is original
and accurate in all respects, and that the submission of such content by you
and the posting of such content by Barnes & Noble.com does not and will not
violate the rights of any third party. Please follow the rules below to help
ensure that your review can be posted.
Reviews by Our Customers Under the Age of 13
We highly value and respect everyone's opinion concerning the titles we offer.
However, we cannot allow persons under the age of 13 to have accounts at BN.com or
to post customer reviews. Please see our Terms of Use for more details.
What to exclude from your review:
Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the
information on the product page, please send us an email.
Reviews should not contain any of the following:
- HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
- Time-sensitive information such as tour dates, signings, lectures, etc.
- Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
- Comments focusing on the author or that may ruin the ending for others
- Phone numbers, addresses, URLs
- Pricing and availability information or alternative ordering information
- Advertisements or commercial solicitation
Reminder:
- By submitting a review, you grant to Barnes & Noble.com and its
sublicensees the royalty-free, perpetual, irrevocable right and license to use the
review in accordance with the Barnes & Noble.com Terms of Use.
- Barnes & Noble.com reserves the right not to post any review -- particularly
those that do not follow the terms and conditions of these Rules. Barnes & Noble.com
also reserves the right to remove any review at any time without notice.
- See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend
Create a Pen Name
Welcome, penname
You have successfully created your Pen Name. Start enjoying the benefits of the BN.com Community today.
If you find inappropriate content, please report it to Barnes & Noble
Overview